m+Medelevator.RU
← Поиск публикаций
Respiratory medicine case reports · 2025

Community-acquired pneumonia caused by Kluyvera intermedia: A rare case report.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Xu Li, Zhu XiaoLong, Liu Yi

Аннотация

BACKGROUND: Kluyvera intermedia is a rare Gram-negative bacillus that predominantly functions as an opportunistic pathogen. Commonly found in environmental sources such as freshwater and soil, it has been infrequently reported in human infections, often leading to underrecognition in clinical practice. Because it can resemble more prevalent pathogens, accurate identification is crucial for effective management of infections.

CASE REPORT: We report a case of pneumonia caused by Kluyvera intermedia in a 55-year-old male with a 10-year history of well-controlled hypertension. The patient initially presented with classic pneumonia symptoms, including fever, cough, and right-sided chest pain. Although he received empirical treatment with Cefotaxime Sodium and Levofloxacin at the local hospital, follow-up CT scans revealed further enlargement of the pulmonary lesions. To investigate the underlying etiology, the patient underwent MRI-guided lung biopsy at our hospital, and culture of the aspirated fluid identified Kluyvera intermedia as the causative pathogen. He was subsequently treated with Ceftizoxime sodium and Levonidazole Sodium Chloride Injection, resulting in significant clinical improvement. The patient was discharged after 22 days of hospitalization.

CONCLUSION: Further accumulation and reporting of cases will enhance the recognition of the clinical characteristics of Kluyvera intermedia. These studies will not only expand our understanding of this rare pathogen but also provide a foundation for improved response strategies, thereby ensuring better management of similar infections in future clinical practice.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты